Risk factors for chronic renal dysfunction in cardiac allograft recipients

被引:33
作者
Esposito, C
Semeraro, L
Bellotti, N
Fasoli, G
Fornoni, A
Rampino, T
Klersy, C
Campana, C
Gavazzi, A
Viganò, M
Dal Canton, A
机构
[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Internal Med & Nephrol, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, IRCCS, Policlin San Matteo, Sci Adm, I-27100 Pavia, Italy
来源
NEPHRON | 2000年 / 84卷 / 01期
关键词
cardiac allograft recipients; renal function; heart transplantation; ciclosporin;
D O I
10.1159/000045534
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is one of the most common and threatening complications in heart transplant recipients. Even if ciclosporin seems to play a central role in inducing renal damage, other factors may concur or predispose to renal injury. In order to identify factors responsible for renal dysfunction, we retrospectively studied a cohort of 114 cardiac transplant recipients during a follow-up period of at least 3 years. The patients had a normal renal function before and 0.5 months after heart transplantation. Doubling of baseline serum creatinine or attainment of serum creatinine steadily above 176.8 mu mol/l (2.0 mg/dl) was used as criterion to define the end-point renal dysfunction. A series of clinical and laboratory variables were obtained from the patients' charts at different time intervals, and their prognostic value for the occurrence of renal dysfunction was calculated by Cox proportional hazards models. 23 out of 114 patients reached the end point after a median time period of 21 months. High serum triglyceride, alanine aminotransferase, alkaline phosphatase, ciclosporin, urea, glucose, and hemoglobin levels were shown to be associated with the development of renal dysfunction. Four variables, i.e., triglyceride, ciclosporin, urea, and alkaline phosphatase, had an independent prognostic value. Our results confirm a role for ciclosporin in inducing renal dysfunction and identify hyperlipidemia and an increased plasma urea level as risk factors for renal dysfunction in heart transplant recipients. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 43 条
[1]  
AGRESTI A, 1990, MODEL MATCHED PAIRS, P348
[2]  
[Anonymous], 1988, DIS KIDNEY
[3]   HYPERLIPIDEMIA AFTER HEART-TRANSPLANTATION - REPORT OF A 6-YEAR EXPERIENCE, WITH TREATMENT RECOMMENDATIONS [J].
BALLANTYNE, CM ;
RADOVANCEVIC, B ;
FARMER, JA ;
FRAZIER, OH ;
CHANDLER, L ;
PAYTONROSS, C ;
COCANOUGHER, B ;
JONES, PH ;
YOUNG, JB ;
GOTTO, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) :1315-1321
[4]  
Benigni A, 1996, SEMIN NEPHROL, V16, P151
[5]   NATURE AND EXTENT OF GLOMERULAR INJURY INDUCED BY CYCLOSPORINE IN HEART-TRANSPLANT PATIENTS [J].
BERTANI, T ;
FERRAZZI, P ;
SCHIEPPATI, A ;
RUGGENENTI, P ;
GAMBA, A ;
PARENZAN, L ;
MECCA, G ;
PERICO, N ;
IMBERTI, O ;
REMUZZI, A ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1991, 40 (02) :243-250
[6]   ADRENAL MINERALOCORTICOIDS CAUSING HYPERTENSION [J].
BIGLIERI, EG ;
SCHAMBELAN, M ;
STOCKIGT, JR .
AMERICAN JOURNAL OF MEDICINE, 1972, 52 (05) :623-+
[7]  
BLUHM RE, 1992, ALIMENT PHARM THERAP, V6, P207
[8]   The hyperfiltration theory: A paradigm shift in nephrology [J].
Brenner, BM ;
Lawler, EV ;
Mackenzie, HS .
KIDNEY INTERNATIONAL, 1996, 49 (06) :1774-1777
[9]  
BRENNER BM, 1985, AM J PHYSIOL, V249, P324
[10]  
BRINER VA, 1993, TRANSPLANT INT, V6, P99, DOI 10.1007/BF00336653